Drug Shortage Report for SANDOZ DICLOFENAC RAPIDE
Report ID | 102579 |
Drug Identification Number | 02261774 |
Brand name | SANDOZ DICLOFENAC RAPIDE |
Common or Proper name | DICLOFENAC RAP |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC POTASSIUM |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-12-20 |
Estimated end date | 2020-02-14 |
Actual end date | 2020-01-31 |
Shortage status | Resolved |
Updated date | 2020-02-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-15 | French | Compare |
v3 | 2020-02-15 | English | Compare |
v2 | 2020-01-08 | French | Compare |
v1 | 2020-01-08 | English | Compare |
Showing 1 to 4 of 4